Ellis IO - Search Results

1

Growth fraction as a predictor of response to chemotherapy in node-negative breast cancer.

Aleskandarany MA, Green AR, Rakha EA, Mohammed RA, Elsheikh SE, Powe DG, Paish EC, Macmillan RD, Chan S, Ahmed SI, Ellis IO. Aleskandarany MA, et al. Among authors: ellis io. Int J Cancer. 2010 Apr 1;126(7):1761-9. doi: 10.1002/ijc.24860. Int J Cancer. 2010. PMID: 19711345

2

Loss of CD55 is associated with aggressive breast tumors.

Madjd Z, Durrant LG, Bradley R, Spendlove I, Ellis IO, Pinder SE. Madjd Z, et al. Among authors: ellis io. Clin Cancer Res. 2004 Apr 15;10(8):2797-803. doi: 10.1158/1078-0432.ccr-1073-03. Clin Cancer Res. 2004. PMID: 15102687

3

Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis.

Rakha EA, Pinder SE, Paish EC, Robertson JF, Ellis IO. Rakha EA, et al. Among authors: ellis io. J Pathol. 2004 Jul;203(3):754-61. doi: 10.1002/path.1573. J Pathol. 2004. PMID: 15221934

4

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis.

Putti TC, El-Rehim DM, Rakha EA, Paish CE, Lee AH, Pinder SE, Ellis IO. Putti TC, et al. Among authors: ellis io. Mod Pathol. 2005 Jan;18(1):26-35. doi: 10.1038/modpathol.3800255. Mod Pathol. 2005. PMID: 15332092 Free article.

5

Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)?

Madjd Z, Durrant LG, Pinder SE, Ellis IO, Ronan J, Lewis S, Rushmere NK, Spendlove I. Madjd Z, et al. Among authors: ellis io. Cancer Immunol Immunother. 2005 Feb;54(2):149-56. doi: 10.1007/s00262-004-0590-0. Epub 2004 Sep 16. Cancer Immunol Immunother. 2005. PMID: 15378282 Free PMC article.

6

High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry.

Rakha EA, Armour JA, Pinder SE, Paish CE, Ellis IO. Rakha EA, et al. Among authors: ellis io. Int J Cancer. 2005 May 1;114(5):720-9. doi: 10.1002/ijc.20738. Int J Cancer. 2005. PMID: 15609312

7

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.

Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, Macmillan D, Blamey RW, Ellis IO. Abd El-Rehim DM, et al. Among authors: ellis io. Int J Cancer. 2005 Sep 1;116(3):340-50. doi: 10.1002/ijc.21004. Int J Cancer. 2005. PMID: 15818618

8

Total loss of MHC class I is an independent indicator of good prognosis in breast cancer.

Madjd Z, Spendlove I, Pinder SE, Ellis IO, Durrant LG. Madjd Z, et al. Among authors: ellis io. Int J Cancer. 2005 Nov 1;117(2):248-55. doi: 10.1002/ijc.21163. Int J Cancer. 2005. PMID: 15900607

9

Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.

Rakha EA, Boyce RW, Abd El-Rehim D, Kurien T, Green AR, Paish EC, Robertson JF, Ellis IO. Rakha EA, et al. Among authors: ellis io. Mod Pathol. 2005 Oct;18(10):1295-304. doi: 10.1038/modpathol.3800445. Mod Pathol. 2005. PMID: 15976813 Free article.

10

Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.

Watson NF, Ramage JM, Madjd Z, Spendlove I, Ellis IO, Scholefield JH, Durrant LG. Watson NF, et al. Among authors: ellis io. Int J Cancer. 2006 Jan 1;118(1):6-10. doi: 10.1002/ijc.21303. Int J Cancer. 2006. PMID: 16003753

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

771 results

Search Page

Filters